We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $18.6M invested in Tonix Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
0.89% more ownership
Funds ownership: 24.4% → 25.3% (+0.89%)
61% less call options, than puts
Call options by funds: $436K | Put options by funds: $1.1M
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $1.55M
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$436K
Puts
$1.1M
Net Calls
-$669K
Net Calls Change
+$632K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.32M |
| 2 |
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$178K |
| 3 |
First Manhattan
New York
|
-$50K |
| 4 |
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$1K |